Results 41 to 50 of about 98,340 (384)

Emerging Role of Biopharmaceutical Classification and Biopharmaceutical Drug Disposition System in Dosage form Development: A Systematic Review.

open access: yesTurkish Journal of Pharmaceutical Sciences, 2021
Biopharmaceutical classification system (BCS) is an advanced tool used for classifying medicines based on dissolution, water solubility, and intestinal permeability, which affect the absorption of active pharmaceutical ingredients (API) from immediate ...
R. Samineni   +2 more
semanticscholar   +1 more source

Carcinogenicity of Biopharmaceuticals [PDF]

open access: yes, 2015
This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical ...
Dempster, M   +8 more
openaire   +3 more sources

Bioreactor control systems in the biopharmaceutical industry: a critical perspective

open access: yesSystems Microbiology and Biomanufacturing, 2021
Industrial-scale bioprocessing underpins much of the production of pharmaceuticals, nutraceuticals, food, and beverage processing industries of the modern world. The profitability of these processes increasingly leverages the economies of scale and scope
Sagnik Mitra, G. Murthy
semanticscholar   +1 more source

University–industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry

open access: yesJournal of Technology Transfer, 2021
Existing research has shown that university–industry collaboration (UIC) helps a firm achieve superior innovation outcomes. However, little is known about how UIC affects firm innovation when considering interfirm alliances. In this paper, we examine the
Mingyu Tian, Yi Su, Zhong Yang
semanticscholar   +1 more source

The biopharmaceutical anomaly [PDF]

open access: yesNature Biotechnology, 2020
Investment and funding has continued to flow into biotech, unlike most business sectors. But with healthcare and hospital budgets increasingly under pressure, do belt-tightening and consolidation lie ahead? Melanie Senior investigates, with additional reporting by Riku Lahteenmaki.
openaire   +3 more sources

Cell-free protein synthesis: advances on production process for biopharmaceuticals and immunobiological products

open access: yesBioTechniques, 2021
Biopharmaceutical products are of great importance in the treatment or prevention of many diseases and represent a growing share of the global pharmaceutical market.
Camila Hiromi Chiba   +4 more
doaj   +1 more source

Cyberbiosecurity for Biopharmaceutical Products [PDF]

open access: yesFrontiers in Bioengineering and Biotechnology, 2019
Cyberbiosecurity is an emerging discipline that addresses the unique vulnerabilities and threats that occur at the intersection of cyberspace and biotechnology. Advances in technology and manufacturing are increasing the relevance of cyberbiosecurity to the biopharmaceutical manufacturing community in the United States.
Jennifer L. Mantle   +11 more
openaire   +4 more sources

SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?

open access: yesПедиатрическая фармакология, 2013
A considerable number of biopharmaceuticals have recently been introduced into clinical practice. Their role is becoming more and more important in managing various diseases, including incapacitating and life-threatening diseases.
A. S. Kolbin, A. V. Kharchev
doaj   +1 more source

Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering

open access: yesPharmaceutics, 2021
Active pharmaceutical ingredients (APIs) extracted and isolated from traditional Chinese medicines (TCMs) are of interest for drug development due to their wide range of biological activities.
Danyingzi Guan   +9 more
semanticscholar   +1 more source

Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies

open access: yesMolecules, 2020
Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR).
Camille Lombard-Banek, John E. Schiel
doaj   +1 more source

Home - About - Disclaimer - Privacy